The Utilization and Limitation of Genetic Information in Insurance — Improvement Plan of China’s“Genetic Non-discrimination Act”|RISS 상세보기

다국어 초록 (Multilingual Abstract)

According to current Chinese law, insurance companies cannot use genetic information for medical, disease, disability, care and medical accident insurance. Nevertheless, this approach has not effectively solved the problem of “genetic discrimination” in China. Genetic information plays a vital role in insurance. The theory that genetic information can be used in insurance is based on risk classification and price equilibrium principle. Adverse selection can be avoided by dividing genetic information into different risk classes. This is an inevitable requirement of the insurer's right to know. For the consideration of social and public interests, commercial insurance should undertake a reasonable social relief function, but it is necessary to clarify the limitations of the social relief function of commercial insurance, and commercial insurance and social insurance cannot be equated. In terms of the characteristics of genetic information itself, there is no substantial difference between it and general medical information. Insurance covers uncertain risks, and with the progress of technology, the accuracy of genetic testing has also been improved. Therefore, theoretically speaking, it is not necessary to completely prohibit insurers from using genetic information in the insurance field. Therefore, in the future, China's legislation on genetic discrimination should be changed from completely prohibiting the use of genetic information by insurers to conditionally restricting the use of genetic information by insurers. First of all, the way to obtain genetic information by the insurer should be clarified, and the insurer should be prohibited from forcing the insured to carry out predictive genetic testing. The insurance applicant only must inform the specific genetic testing results. Secondly, it is necessary to set conditions for the insurer to use genetic information. The insurer can only use genetic information in personal insurance that meets a certain amount of money, and the use of genetic information must meet legal procedures and obtain the consent of the insured. In addition, it is also necessary to strengthen the regulation of the gene testing industry, formulate strict market access rules, and establish a gene consultant system to make up for the inferior position of the insured in the profession. Finally, improve the rescue of the insured, let professionals participate in the settlement of disputes, and increase the severity of punishment for the illegal use of genetic information by insurance companies.

번역하기

참고문헌 (Reference)

1 McGuire A. L., "Two cheers for GINA?" 1 (1): 2009

2 Ibon Santiago, "The World Wide Genome: Genetic Privacy in the Age of Big Data"

3 Nill A, "The Use of Genetic Testing Information in the Insurance Industry: An Ethical and Societal Analysis of Public Policy Options" 156 : 2019

4 Geng ShanShan, "The Legal Regulation of Commercial Genetic Testing" 27 (27):

5 Macdonald A, "The Impact of Genetic Information on the Insurance Industry: Conclusions from the ‘Bottom-Up’ Modelling Programme" 41 (41): 2011

6 Wu YiWen, "The Application and Limitation of Genetic Information in Insurance Underwriting" 1 : 2020

7 Zhou XueFeng, "Risk Classification in Insurance Law: Reasonable Distinction v. Discrimination" (2) : 2014

8 Song LingQiao, "Revisiting Genetic Discrimination: Ethical, Legal, and Social Implications to be Considered" 4 :

9 Prince, A. E. R., "Political economy, stakeholder voices, and saliency: lessons from international policies regulating insurer use of genetic information" 5 : 2018

10 Wang Qian, "On ‘Genetic Discrimination’ and Its Legal Countermeasures" Renmin University of China Press